Block of rat brain recombinant SK channels by tricyclic antidepressants and related compounds

European Journal of Pharmacology

Volumn 401, Issue 1, 2000, Pages 1-7

  Dreixler, John C ^a   Bian, Jing Tan ^a   Cao, Ying Jun ^a   Roberts, Michael T ^a   Roizen, Jeffrey D ^a   Houamed, Khaled M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Antipsychotic; Calcium; Calmodulin; Dequalinium; K+ channel; Patch clamp

Indexed keywords

CALCIUM ION; CALMODULIN; CARBAMAZEPINE; CHLORPROMAZINE; CYPROHEPTADINE; IMIPRAMINE; LINOPIRDINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; TACRINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIFLUOPERAZINE;

AFTERHYPERPOLARIZATION; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; HUMAN; HUMAN CELL; KIDNEY CELL CULTURE; NONHUMAN; PATCH CLAMP; PERFUSION; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BRAIN; CELL LINE; DEQUALINIUM; DNA, RECOMBINANT; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HUMANS; INDOLES; MEMBRANE POTENTIALS; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; PYRIDINES; RATS; SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS;

EID: 0034726037     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00401-5     Document Type: Article

References (36)

1. Agopyan N., Krnjevic K. Effects of trifluoperazine on synaptically evoked potentials and membrane properties of CA1 pyramidal neurons of rat hippocampus in situ and in vitro. Synapse. 13:1993;10-19.
2. Aiken S.P., Lampe B.J., Murphy P.A., Brown B.S. Reduction of spike frequency adaptation and blockade of M-current in rat CA1 pyramidal neurones by linopirdine (DUP 996), a neurotransmitter release enhancer. Br. J. Pharmacol. 115:1995;1163-1168.
3. Behnisch T., Reymann K.G. Inhibition of apamin-sensitive calcium dependent potassium channels facilitate the induction of long-term potentiation in the CA1 region of rat hippocampus in vitro. Neurosci. Lett. 253:1998;91-94.
4. Chandy K.G., Fantino E., Wittekindt O., Kalman K., Tong L.L., Ho T.H., Gutman G.A., Crocq M.A., Ganguli R., Nimgaonkar V., Morris-Rosendahl D.J., Gargus J.J. Isolation of a novel potassium channel gene hSKCa3 containing a polymorphic CAG repeat: a candidate for schizophrenia and bipolar disorder? Mol. Psychiatry. 3:1998;32-37.
5. Dinan T.G., Crunelli V., Kelly J.S. Neuroleptics decrease calcium-activated potassium conductance in hippocampal pyramidal cells. Brain Res. 407:1987;159-162.
6. Dror V., Shamir E., Ghanshani S., Kimhi R., Swartz M., Barak Y., Weizman R., Avivi L., Litmanovitch T., Fantino E., Kalman K., Jones E.G., Chandy K.G., Gargus J.J., Gutman G.A., Navon R. hKCa3/KCNN3 potassium channel gene: association of longer CAG repeats with schizophrenia in Israeli Ashkenazi Jews, expression in human tissues and localization to chromosome 1q21. Mol. Psychiatry. 4:1999;254-260.
7. Dunn P.M., Benton D.C., Campos Rosa J., Ganellin C.R., Jenkinson D.H. Discrimination between subtypes of apamin-sensitive Ca(2+)-activated K+ channels by gallamine and a novel bis-quaternary quinolinium cyclophane, UCL 1530. Br. J. Pharmacol. 117:1996;35-42.
8. Fanger C.M., Ghanshani S., Logsdon N.J., Rauer H., Kalman K., Zhou J., Beckingham K., Chandy K.G., Cahalan M.D., Aiyar J. Calmodulin mediates calcium-dependent activation of the intermediate conductance KCa channel, IKCa1. J. Biol. Chem. 274:1999;5746-5754.
9. Gandolfo G., Schweitz H., Lazdunski M., Gottesmann C. Sleep cycle disturbances induced by apamin, a selective blocker of Ca(2+)-activated K+ channels. Brain Res. 736:1996;344-347.
10. Ghelardini C., Galeotti N., Bartolini A. Influence of potassium channel modulators on cognitive processes in mice. Br. J. Pharmacol. 123:1998;1079-1084.
11. Gurevich N., Wu P.H., Carlen P.L. Serotonin agonist and antagonist actions in hippocampal CA1 neurons. Can. J. Physiol. Pharmacol. 68:1990;586-595.
12. Halliwell J.V., Grove E.A. 9-Amino-1,2,3,4-tetrahydroacridine (THA) blocks agonist-induced potassium conductance in rat hippocampal neurones. Eur. J. Pharmacol. 163:1989;369-372.
13. Heurteaux C., Messier C., Destrade C., Lazdunski M. Memory processing and apamin induce immediate early gene expression in mouse brain. Mol. Brain Res. 18:1993;17-22.
14. Ikemoto Y., Yoshida A., Oda M. Blockade by trifluoperazine of a Ca(2+)-activated K+ channel in rat hippocampal pyramidal neurons. Eur. J. Pharmacol. 216:1992;191-198.
15. Kohler M., Hirschberg B., Bond C.T., Kinzie J.M., Marrion N.V., Maylie J., Adelman J.P. Small-conductance, calcium-activated potassium channels from mammalian brain. Science. 273:1996;1709-1714.
16. Kuo C.C. Imipramine inhibition of transient K+ current: an external open channel blocker preventing fast inactivation. Biophys. J. 75:1998;2845-2857.
17. Lamas J.A., Selyanko A.A., Brown D.A. Effects of a cognition-enhancer, linopirdine (DuP 996), on M-type potassium currents (IK(M)) and some other voltage- and ligand-gated membrane currents in rat sympathetic neurons. Eur. J. Neurosci. 9:1997;605-616.
18. Lee K., McKenna F., Rowe I.C., Ashford M.L. The effects of neuroleptic and tricyclic compounds on BKCa channel activity in rat isolated cortical neurones. Br. J. Pharmacol. 121:1997;1810-1816.
19. Mathie A., Wooltorton J.R., Watkins C.S. Voltage-activated potassium channels in mammalian neurons and their block by novel pharmacological agents. Gen. Pharmacol. 30:1998;13-24.
20. McLean M.J., Macdonald R.L. Carbamazepine and 10,11-epoxycarbamazepine produce use- and voltage-dependent limitation of rapidly firing action potentials of mouse central neurons in cell culture. J. Pharmacol. Exp. Ther. 238:1986;727-738.
21. Nakazawa K., Ito K., Koizumi S., Ohno Y., Inoue K. Characterization of inhibition by haloperidol and chlorpromazine of a voltage-activated K+ current in rat phaeochromocytoma cells. Br. J. Pharmacol. 116:1995;2603-2610.
22. Robbins J., Sim J.A. A transient outward current in NG108-15 neuroblastoma x glioma hybrid cells. Pfluegers Arch. 416:1990;130-137.
23. Rogawski M.A. Tetrahydroaminoacridine blocks voltage-dependent ion channels in hippocampal neurons. Eur. J. Pharmacol. 142:1987;169-172.
24. Sah P. Ca(2+)-activated K+ currents in neurones: types, physiological roles and modulation. Trends Neurosci. 19:1996;150-154.
25. Sander T., Scholz L., Janz D., Epplen J.T., Riess O. Length variation of a polyglutamine array in the gene encoding a small-conductance, calcium-activated potassium channel (hKCa3) and susceptibility to idiopathic generalized epilepsy. Epilepsy Res. 33:1999;227-233.
26. Schnee M.E., Brown B.S. Selectivity of linopirdine (DuP 996), a neurotransmitter release enhancer, in blocking voltage-dependent and calcium-activated potassium currents in hippocampal neurons. J. Pharmacol. Exp. Ther. 286:1998;709-717.
27. Schwarz J.R., Grigat G. Phenytoin and carbamazepine: potential- and frequency-dependent block of Na currents in mammalian myelinated nerve fibers. Epilepsia. 30:1989;286-294.
28. Stocker M., Krause M., Pedarzani P. An apamin-sensitive Ca2+-activated K+ current in hippocampal pyramidal neurons. Proc. Natl. Acad. Sci. U.S.A. 96:1999;4662-4667.
29. Strobaek D., Jorgensen T.D., Christophersen P., Ahring P.K., Olesen S.-P. Pharmacological characterization of small-conductance Ca(2+)-activated K(+) channels stably expressed in HEK 293 cells. Br. J. Pharmacol. 129:2000;991-999.
30. Vergara C., Latorre R., Marrion N.V., Adelman J.P. Calcium-activated potassium channels. Curr. Opin. Neurobiol. 8:1998;321-329.
31. Verma-Ahuja S., Evans M.S., Pencek T.L. Evidence for decreased calcium dependent potassium conductance in hippocampal CA3 neurons of genetically epilepsy-prone rats. Epilepsy Res. 22:1995;137-144.
32. Willow M., Gonoi T., Catterall W.A. Voltage clamp analysis of the inhibitory actions of diphenylhydantoin and carbamazepine on voltage-sensitive sodium channels in neuroblastoma cells. Mol. Pharmacol. 27:1985;549-558.
33. Wooltorton J.R., Mathie A. Block of potassium currents in rat isolated sympathetic neurones by tricyclic antidepressants and structurally related compounds. Br. J. Pharmacol. 110:1993;1126-1132. (published erratum appears in Br. J. Pharmacol. 1994 Jan; 111(1) 377).
34. Wooltorton J.R., Mathie A. Potent block of potassium currents in rat isolated sympathetic neurones by the uncharged form of amitriptyline and related tricyclic compounds. Br. J. Pharmacol. 116:1995;2191-2200.
35. Xia X.M., Fakler B., Rivard A., Wayman G., Johnson-Pais T., Keen J.E., Ishii T., Hirschberg B., Bond C.T., Lutsenko S., Maylie J., Adelman J.P. Mechanism of calcium gating in small-conductance calcium-activated potassium channels. Nature. 395:1998;503-507.
36. Zona C., Tancredi V., Palma E., Pirrone G.C., Avoli M. Potassium currents in rat cortical neurons in culture are enhanced by the antiepileptic drug carbamazepine. Can. J. Physiol. Pharmacol. 68:1990;545-547.